0.931
-0.05 (-5.01%)
| Previous Close | 0.980 |
| Open | 0.890 |
| Volume | 15,576 |
| Avg. Volume (3M) | 215,318 |
| Market Cap | 2,678,773 |
| Price / Sales | 1.52 |
| Price / Book | 0.230 |
| 52 Weeks Range |
| Operating Margin (TTM) | -2,151.43% |
| Diluted EPS (TTM) | -5.05 |
| Quarterly Revenue Growth (YOY) | -79.00% |
| Current Ratio (MRQ) | 1.70 |
| Operating Cash Flow (TTM) | -4.95 M |
| Levered Free Cash Flow (TTM) | -3.00 M |
| Return on Assets (TTM) | -100.63% |
| Return on Equity (TTM) | -218.77% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Tivic Health Systems, Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.3 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 0.0 |
| Relative Valuation | NA |
| Financial Health | -3.0 |
| Macro Environment | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -0.91 |
Select this tab to load the latest available analysis.
|
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body’s own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 12.81% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |